Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Another series of factor Xa inhibitors patented by AxyS

June 25, 1999

AxyS describes further research on factor Xa inhibitors

June 23, 1999

Xenova refocuses research at MetaXen subsidiary

June 22, 1999

Inhibitors of serine proteases in the pipeline at 3-D

June 22, 1999

Schering-Plough scientists prepare thrombin receptor antagonists

June 22, 1999

AxyS claims heterocyclic factor Xa inhibitors

June 22, 1999

Retavase now available in Canada for emergency treatment of heart attacks

June 22, 1999

Carbohydrate anticoagulants with low sulfate content result from European collaboration

June 21, 1999

AHP launches ReFacto hemophilia A treatment in the U.K.

June 21, 1999

Benzocycloheptenes as PGI2 agonists in early development at Fujisawa

June 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...